Benzinga | May 12, 2021 08:08AM EDT

Truist Securities Maintains Buy on Exact Sciences, Lowers Price Target to $168

Truist Securities analyst Sandy Draper maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $226 to $168.